Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis

Abstract

The first step in the generation of genetically tagged human embryonic stem cell (HESC) reporter lines is the isolation of cells that contain a stably integrated copy of the reporter vector. These cells are identified by their continued growth in the presence of a specific selective agent, usually conferred by a cassette encoding antibiotic resistance. In order to mitigate potential interference between the regulatory elements driving expression of the antibiotic resistance gene and those controlling the reporter gene, it is advisable to remove the positive selection cassette once the desired clones have been identified. This report describes a protocol for the removal of loxP-flanked selection cassettes from genetically modified HESCs by transient transfection with a vector expressing Cre recombinase. An integrated procedure for the clonal isolation of these genetically modified lines using single-cell deposition flow cytometry is also detailed. When performed sequentially, these protocols take 1 month.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Morphology of human embryonic stem cells (HESCs) prepared for transfection of the pEFBOS-CreIRESpuro vector by FuGENE 6 Transfection Reagent and following selection in puromycin.
Figure 2: Photomicrographs of human embryonic stem cells (HESCs) cloned by single-cell deposition.
Figure 3: Possible primer locations for human embryonic stem cell (HESC) colony screening for excision of the positive selection cassette.

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Ng, E.S. et al. The primitive streak gene Mixl1 is required for efficient haematopoiesis and BMP4-induced ventral mesoderm patterning in differentiating ES cells. Development 132, 873–884 (2005).

    Article  CAS  PubMed  Google Scholar 

  2. Gadue, P., Huber, T.L., Paddison, P.J. & Keller, G.M. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc. Natl. Acad. Sci. USA 103, 16806–16811 (2006).

    Article  CAS  PubMed  Google Scholar 

  3. Yasunaga, M. et al. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat. Biotechnol. 23, 1542–1550 (2005).

    Article  CAS  Google Scholar 

  4. Micallef, S.J. et al. Endocrine cells develop within pancreatic bud-like structures derived from mouse ES cells differentiated in response to BMP4 and retinoic acid. Stem Cell Res. 1, 25–36 (2007).

    Article  CAS  PubMed  Google Scholar 

  5. Anderson, D. et al. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol. Ther. 15, 2027–2036 (2007).

    Article  CAS  PubMed  Google Scholar 

  6. Hedlund, E. et al. Selection of embryonic stem cell-derived enhanced green fluorescent protein-positive dopamine neurons using the tyrosine hydroxylase promoter is confounded by reporter gene expression in immature cell populations. Stem Cells 25, 1126–1135 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Huber, I. et al. Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J. 21, 2551–2563 (2007).

    Article  CAS  Google Scholar 

  8. Davis, R.P. et al. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 111, 1876–1884 (2008).

    Article  CAS  PubMed  Google Scholar 

  9. Hug, B.A. et al. Analysis of mice containing a targeted deletion of beta-globin locus control region 5′ hypersensitive site 3. Mol. Cell. Biol. 16, 2906–2912 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Pham, C.T., MacIvor, D.M., Hug, B.A., Heusel, J.W. & Ley, T.J. Long-range disruption of gene expression by a selectable marker cassette. Proc. Natl. Acad. Sci. USA 93, 13090–13095 (1996).

    Article  CAS  PubMed  Google Scholar 

  11. Scacheri, P.C. et al. Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis 30, 259–263 (2001).

    Article  CAS  PubMed  Google Scholar 

  12. Branda, C.S. & Dymecki, S.M. Talking about a revolution: review. The impact of site-specific recombinases on genetic analyses in mice. Dev. Cell 6, 7–28 (2004).

    Article  CAS  Google Scholar 

  13. von Melchner, H. & Stewart, A.F. Engineering of ES cell genomes with recombinase systems. Methods Enzymol 420, 100–136 (2006).

    Article  PubMed  Google Scholar 

  14. Nolden, L. et al. Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase. Nat. Methods 3, 461–467 (2006).

    Article  CAS  PubMed  Google Scholar 

  15. Taniguchi, M. et al. Efficient production of Cre-mediated site-directed recombinants through the utilization of the puromycin resistance gene, pac: a transient gene-integration marker for ES cells. Nucleic Acids Res. 26, 679–680 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Costa, M. et al. A method for genetic modification of human embryonic stem cells using electroporation. Nat. Protoc. 2, 792–796 (2007).

    Article  CAS  PubMed  Google Scholar 

  17. Ng, E.S., Davis, R., Stanley, E.G. & Elefanty, A.G. A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat. Protoc. 3, 768–776 (2008).

    Article  CAS  PubMed  Google Scholar 

  18. Vallier, L., Alexander, M. & Pedersen, R. Conditional gene expression in human embryonic stem cells. Stem Cells 25, 1490–1497 (2007).

    Article  CAS  PubMed  Google Scholar 

  19. Thyagarajan, B. et al. Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells 26, 119–126 (2007).

    Article  PubMed  Google Scholar 

  20. Costa, M., Sourris, K., Hatzistavrou, T., Elefanty, A.G. & Stanley, E.G. Expansion of human embryonic stem cells in vitro. Curr. Protoc. Stem Cell Biol. 1, 1C.1.1–1C.1.7 (2007).

    Google Scholar 

  21. Watanabe, K. et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681–686 (2007).

    Article  CAS  PubMed  Google Scholar 

  22. Barnett, L.D. & Kontgen, F. Gene targeting in a centralized facility. Methods Mol. Biol. 158, 65–82 (2001).

    CAS  Google Scholar 

  23. Amit, M. et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271–278 (2000).

    Article  CAS  Google Scholar 

  24. Xu, R.H. et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2, 185–190 (2005).

    Article  CAS  PubMed  Google Scholar 

  25. Köntgen, F. & Stewart, C.L. Simple screening procedure to detect gene targeting events in embryonic stem cells. Methods Enzymol. 225, 878–890 (1993).

    Article  PubMed  Google Scholar 

  26. Reubinoff, B.E., Pera, M.F., Vajta, G. & Trounson, A.O. Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum. Reprod. 16, 2187–2194 (2001).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Robyn Mayberry, Kathy Koutsis and Amanda Bruce for the provision of HESCs. This work was supported by the Australian Stem Cell Centre, the National Health and Medical Research Council of Australia (NHMRC) and the Juvenile Diabetes Research Foundation. A.G.E. is a senior research fellow of the NHMRC.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edouard G Stanley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, R., Costa, M., Grandela, C. et al. A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis. Nat Protoc 3, 1550–1558 (2008). https://doi.org/10.1038/nprot.2008.146

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nprot.2008.146

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing